,Set,NGenes,Direction,PValue,FDR
1,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,6.51126066572933e-14,5.35225626722951e-11
2,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,3.71858588705001e-11,1.52833879957755e-08
3,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,2.019848656011e-09,5.53438531747015e-07
4,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,27,Up,2.50830854556289e-07,5.15457406113174e-05
5,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,4.89315755563673e-05,0.00804435102146679
6,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,8.47366392990214e-05,0.0116089195839659
7,WP_PEPTIDE_GPCRS,12,Up,0.000115791504550048,0.0135972309628771
8,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,0.000181034526477182,0.0186012975955305
9,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Up,0.000256798065642513,0.0222417373965649
10,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,35,Down,0.000306765280205308,0.0222417373965649
11,WP_MEVALONATE_PATHWAY,7,Up,0.000318227736661119,0.0222417373965649
12,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,40,Up,0.000324696896300217,0.0222417373965649
13,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,11,Up,0.000789631791493505,0.0499290255852047
14,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.00142644168402807,0.0837525045907908
15,WP_OXIDATIVE_PHOSPHORYLATION,50,Down,0.00213221718074112,0.116845501504613
16,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,24,Down,0.00231391493444593,0.11887737975716
17,WP_NUCLEAR_RECEPTORS,20,Down,0.00278680794753175,0.134750360757124
18,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,33,Up,0.00326414948406543,0.141431252492184
19,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,10,Up,0.00328922313688351,0.141431252492184
20,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Down,0.00344114969567357,0.141431252492184
21,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Up,0.00496695732469968,0.194420900995388
22,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Down,0.00661269531357997,0.247074343080124
23,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Up,0.00790980841565074,0.279084942400182
24,WP_GPCRS_CLASS_A_RHODOPSINLIKE,40,Up,0.00814846547153817,0.279084942400182
25,WP_CILIOPATHIES,127,Up,0.0101518828426531,0.321629399650076
26,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,5,Up,0.0101731926896618,0.321629399650076
27,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Down,0.010963515593299,0.333778141395993
28,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.012538910911099,0.368106598890121
29,WP_BARDETBIEDL_SYNDROME,65,Up,0.0152176463650296,0.431341562484633
30,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,27,Up,0.0167236556553723,0.458228164957202
31,WP_CHOLESTEROL_METABOLISM,50,Up,0.0183767391763091,0.487279987191165
32,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.0192052998828098,0.493336140739676
33,WP_CREATINE_PATHWAY,2,Down,0.0200630199631067,0.494032802345496
34,WP_SPINA_BIFIDA,10,Down,0.0204344468123441,0.494032802345496
35,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.0215050401871597,0.500609426730917
36,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Down,0.0221217856906691,0.500609426730917
37,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,12,Up,0.0225335143419026,0.500609426730917
38,WP_ALSTROM_SYNDROME,26,Up,0.0232796816798724,0.503576272127766
39,WP_IRON_METABOLISM_IN_PLACENTA,10,Down,0.0241634496278761,0.509291169079849
40,WP_JOUBERT_SYNDROME,70,Up,0.025982080798547,0.533931760410141
41,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.0267946504499663,0.537200065118836
42,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Up,0.0276488627070343,0.541127741551957
43,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.028751216326661,0.545061249502352
44,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,75,Up,0.0300589323377956,0.545061249502352
45,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.03032444784919,0.545061249502352
46,WP_CELL_CYCLE,108,Up,0.0305022110427107,0.545061249502352
47,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.0329631936044021,0.554150336368748
48,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.0329637684945683,0.554150336368748
49,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Up,0.033804928264007,0.554150336368748
50,WP_CHOLESTASIS,9,Up,0.033897055231219,0.554150336368748
51,WP_IL18_SIGNALING,190,Down,0.0343815902126595,0.554150336368748
52,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.0361252252005614,0.560870306074505
53,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Down,0.0361631705863124,0.560870306074505
54,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Down,0.0370438312185557,0.563889430771348
55,WP_ENDOTHELIN_PATHWAYS,13,Up,0.0381466822391099,0.570119505464515
56,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.0403683204612696,0.571588233843114
57,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,24,Up,0.0404702725028467,0.571588233843114
58,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,51,Up,0.0407852324972485,0.571588233843114
59,WP_SERINE_METABOLISM,8,Up,0.0416461969395289,0.571588233843114
60,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,20,Down,0.0417217688936579,0.571588233843114
61,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,10,Up,0.0431217637813694,0.571902693118955
62,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Up,0.0431362128629869,0.571902693118955
63,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,89,Down,0.0461614637067121,0.602297193125672
64,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.048732875796215,0.615470534798561
65,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Up,0.048998218741636,0.615470534798561
66,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Down,0.0497817354524933,0.615470534798561
67,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,89,Up,0.0501660898193474,0.615470534798561
68,WP_ENDODERM_DIFFERENTIATION,80,Down,0.0515650996634254,0.619396299859042
69,WP_HEART_DEVELOPMENT,16,Up,0.0519931200611604,0.619396299859042
70,WP_KALLMANN_SYNDROME,11,Up,0.0532747049411267,0.625597249451516
71,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,65,Up,0.0570379419781568,0.660354764873871
72,WP_FOLATE_METABOLISM,36,Down,0.0579529887957054,0.661629955417637
73,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,53,Up,0.0596792011412272,0.663261988004506
74,WP_NEPHROGENESIS,4,Down,0.0597097166816709,0.663261988004506
75,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.0629066032045569,0.678985938893999
76,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,49,Down,0.0636256623227052,0.678985938893999
77,WP_THERMOGENESIS,74,Up,0.0657962802218196,0.678985938893999
78,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Up,0.0663687820962744,0.678985938893999
79,WP_RETINOBLASTOMA_GENE_IN_CANCER,85,Up,0.0663693469842776,0.678985938893999
80,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,14,Down,0.0664537147583408,0.678985938893999
81,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.0669073735406496,0.678985938893999
82,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,14,Up,0.0710836233043903,0.702284010430265
83,WP_10Q22Q23_COPY_NUMBER_VARIATION,28,Up,0.0715171658792095,0.702284010430265
84,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,50,Up,0.0727211848745005,0.702284010430265
85,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,16,Down,0.0746371445162313,0.702284010430265
86,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.0752406513195197,0.702284010430265
87,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Up,0.0756248073864045,0.702284010430265
88,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Up,0.0767660120222641,0.702284010430265
89,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.0770122527091559,0.702284010430265
90,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Down,0.0800974455416995,0.702284010430265
91,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Up,0.0812673272345214,0.702284010430265
92,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Down,0.0815394520095861,0.702284010430265
93,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.0818267481571274,0.702284010430265
94,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.0822861411393443,0.702284010430265
95,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.0825371878518935,0.702284010430265
96,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,6,Up,0.0835422795502585,0.702284010430265
97,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.0835497600808136,0.702284010430265
98,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,15,Up,0.0837272907812239,0.702284010430265
99,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,26,Down,0.0870650817941957,0.718947444137494
100,WP_NPHP1_DELETION_SYNDROME,10,Up,0.0883076974631041,0.718947444137494
101,WP_HYPERTROPHY_MODEL,13,Down,0.0883378246446312,0.718947444137494
102,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.0907194075199675,0.721882716240067
103,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.0911551691668052,0.721882716240067
104,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.0913330930522712,0.721882716240067
105,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.0929743521619333,0.722204516088364
106,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.0937340664232488,0.722204516088364
107,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,10,Up,0.0943944539307171,0.722204516088364
108,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,24,Down,0.0949809435541191,0.722204516088364
109,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Up,0.0957667788973622,0.722204516088364
110,WP_PREIMPLANTATION_EMBRYO,21,Down,0.0985753523130086,0.735235601199899
111,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Down,0.101607475900529,0.735235601199899
112,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.101942986732704,0.735235601199899
113,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Up,0.102428373637823,0.735235601199899
114,WP_RAC1PAK1P38MMP2_PATHWAY,53,Up,0.103007150331291,0.735235601199899
115,WP_G1_TO_S_CELL_CYCLE_CONTROL,58,Up,0.10310933034029,0.735235601199899
116,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.10375587559512,0.735235601199899
117,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,56,Up,0.107384473254834,0.751301468551198
118,WP_OREXIN_RECEPTOR_PATHWAY,117,Down,0.107932526540322,0.751301468551198
119,WP_CILIARY_LANDSCAPE,185,Up,0.108765054449626,0.751301468551198
120,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.112390167322207,0.767343442716859
121,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,18,Up,0.11342629838757,0.767343442716859
122,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.114037244015,0.767343442716859
123,WP_VITAMIN_B12_METABOLISM,23,Down,0.114821464056172,0.767343442716859
124,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.116069989494978,0.769431704555416
125,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,14,Down,0.122191725385749,0.803532786136683
126,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,42,Up,0.125456841579384,0.804128774424302
127,WP_16P112_DISTAL_DELETION_SYNDROME,21,Down,0.126128788578285,0.804128774424302
128,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.127218292073433,0.804128774424302
129,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.127647672296415,0.804128774424302
130,WP_G13_SIGNALING,30,Up,0.127920133418135,0.804128774424302
131,WP_OSTEOCLAST_SIGNALING,8,Up,0.128602064607691,0.804128774424302
132,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.129130168155727,0.804128774424302
133,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,14,Down,0.133419842934153,0.824594818735893
134,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.135221912983861,0.824865990285472
135,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.135470691835205,0.824865990285472
136,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.136820786068553,0.826960927561399
137,WP_CCL18_SIGNALING,20,Up,0.139305882640853,0.827667966407431
138,WP_APOPTOSIS_MODULATION_AND_SIGNALING,76,Down,0.139638652233534,0.827667966407431
139,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.140803268451047,0.827667966407431
140,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.140965347076691,0.827667966407431
141,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,75,Up,0.14204640542781,0.828100321004681
142,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Up,0.144240300828203,0.831617111895722
143,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.145014495917868,0.831617111895722
144,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.145684749529178,0.831617111895722
145,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.148746019304751,0.843198319130166
146,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Down,0.15072538659757,0.843198319130166
147,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Down,0.150909908664201,0.843198319130166
148,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.151816728991806,0.843198319130166
149,WP_GLUTATHIONE_METABOLISM,10,Up,0.154031991838671,0.849760384505955
150,WP_ARYLAMINE_METABOLISM,1,Up,0.159376909333996,0.873385463150297
151,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.16445000681793,0.877387273069775
152,WP_NEPHROTIC_SYNDROME,29,Up,0.16529125814333,0.877387273069775
153,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.165924174008378,0.877387273069775
154,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.169793539660239,0.877387273069775
155,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.174608289782683,0.877387273069775
156,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.17470529594454,0.877387273069775
157,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.174940363570842,0.877387273069775
158,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Down,0.175943154273732,0.877387273069775
159,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.177379986485122,0.877387273069775
160,WP_MRNA_PROCESSING,124,Down,0.178289681985897,0.877387273069775
161,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Down,0.178854017951837,0.877387273069775
162,WP_BREAST_CANCER_PATHWAY,88,Up,0.180212149865967,0.877387273069775
163,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Up,0.180484911361269,0.877387273069775
164,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.18053413891558,0.877387273069775
165,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Up,0.181185488836204,0.877387273069775
166,WP_PRION_DISEASE_PATHWAY,28,Up,0.182306160893422,0.877387273069775
167,WP_COPPER_HOMEOSTASIS,40,Up,0.183468570718134,0.877387273069775
168,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.184201085354812,0.877387273069775
169,WP_ESTROGEN_METABOLISM_WP5276,8,Down,0.184406298497584,0.877387273069775
170,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.185872129104242,0.877387273069775
171,WP_EICOSANOID_SYNTHESIS,14,Down,0.186235358801953,0.877387273069775
172,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.18789902686799,0.877387273069775
173,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Down,0.188423876406207,0.877387273069775
174,WP_PURINERGIC_SIGNALING,15,Up,0.188865798013687,0.877387273069775
175,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Up,0.189968685543784,0.877387273069775
176,WP_INTEGRATED_CANCER_PATHWAY,42,Up,0.19018604752646,0.877387273069775
177,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,12,Up,0.192458937537523,0.877387273069775
178,WP_IL26_SIGNALING,31,Down,0.192986855176058,0.877387273069775
179,WP_BENZOAPYRENE_METABOLISM,5,Down,0.19391470658508,0.877387273069775
180,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.193949608211748,0.877387273069775
181,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.198835111864747,0.877387273069775
182,WP_IRON_METABOLISM_DISORDERS,13,Down,0.199629422958731,0.877387273069775
183,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.199662454994484,0.877387273069775
184,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.200110527264791,0.877387273069775
185,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.202107416959666,0.877387273069775
186,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,47,Down,0.203155883874146,0.877387273069775
187,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.204633698290983,0.877387273069775
188,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Up,0.207733675155398,0.877387273069775
189,WP_SILDENAFIL_TREATMENT,11,Down,0.208675892827284,0.877387273069775
190,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.209401473331684,0.877387273069775
191,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.209679489250622,0.877387273069775
192,WP_ADIPOGENESIS,83,Down,0.210422442240934,0.877387273069775
193,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.210507436199893,0.877387273069775
194,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.21132656488438,0.877387273069775
195,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Up,0.211780442708732,0.877387273069775
196,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.212283883846623,0.877387273069775
197,WP_NOTCH_SIGNALING_WP61,49,Up,0.213622591812742,0.877387273069775
198,WP_SMALL_LIGAND_GPCRS,7,Up,0.214826234364726,0.877387273069775
199,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.215933629487422,0.877387273069775
200,WP_IDO_METABOLIC_PATHWAY,6,Down,0.216444353912044,0.877387273069775
201,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.219269729546129,0.877387273069775
202,WP_DISORDERS_IN_KETOLYSIS,5,Up,0.21992389242909,0.877387273069775
203,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.22051334278563,0.877387273069775
204,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.221576950556184,0.877387273069775
205,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Down,0.224166207480326,0.877387273069775
206,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Up,0.224171151839534,0.877387273069775
207,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.224494027774245,0.877387273069775
208,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.225582027897877,0.877387273069775
209,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.226612402124483,0.877387273069775
210,WP_GLUCURONIDATION,7,Up,0.227615245780595,0.877387273069775
211,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,18,Down,0.228696626991612,0.877387273069775
212,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,124,Up,0.230124768290378,0.877387273069775
213,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,39,Up,0.2303205955219,0.877387273069775
214,WP_AMINO_ACID_METABOLISM,57,Up,0.231490696040174,0.877387273069775
215,WP_COMPLEMENT_ACTIVATION,12,Down,0.231512203816332,0.877387273069775
216,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Down,0.232745669835472,0.877387273069775
217,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.233697031570371,0.877387273069775
218,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.234250263034899,0.877387273069775
219,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.235382184038614,0.877387273069775
220,WP_FOXP3_IN_COVID19,9,Up,0.235524997000902,0.877387273069775
221,WP_FOCAL_ADHESION,116,Up,0.236212347823623,0.877387273069775
222,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.237404299143394,0.877387273069775
223,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Up,0.238025987706277,0.877387273069775
224,WP_ASPIRIN_AND_MIRNAS,8,Down,0.24207757880303,0.887275427052039
225,WP_RETT_SYNDROME,31,Down,0.24591331354568,0.887275427052039
226,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,10,Up,0.247845641126711,0.887275427052039
227,WP_VALPROIC_ACID_PATHWAY,9,Down,0.249191269378004,0.887275427052039
228,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Down,0.250842894592353,0.887275427052039
229,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.251522594782021,0.887275427052039
230,WP_MICROTUBULE_CYTOSKELETON_REGULATION,36,Up,0.251567671301041,0.887275427052039
231,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Down,0.252132145385957,0.887275427052039
232,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.253090685887216,0.887275427052039
233,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Down,0.254310341316848,0.887275427052039
234,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,6,Down,0.255408377844068,0.887275427052039
235,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Up,0.256028294012612,0.887275427052039
236,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Up,0.25746956117232,0.887275427052039
237,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Down,0.257474933877097,0.887275427052039
238,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Down,0.258175130316243,0.887275427052039
239,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,20,Down,0.259504593001719,0.887275427052039
240,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,38,Down,0.259549347379158,0.887275427052039
241,WP_FRAGILE_X_SYNDROME,84,Up,0.261008784778966,0.887275427052039
242,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.261217339837705,0.887275427052039
243,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Up,0.262757528538346,0.8888341088828
244,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,60,Up,0.265260836618166,0.893624621721853
245,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,8,Up,0.269650666966131,0.9013797168947
246,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.269755973669217,0.9013797168947
247,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.273991593481322,0.906773263965229
248,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Up,0.274402739845656,0.906773263965229
249,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.274679492369029,0.906773263965229
250,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.276886918237426,0.910123376341877
251,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Down,0.277908719539916,0.910123376341877
252,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,40,Down,0.284298893969203,0.920479940680684
253,WP_ACUTE_MYELOID_LEUKEMIA,56,Up,0.284761385419125,0.920479940680684
254,WP_DNA_DAMAGE_RESPONSE,63,Up,0.285222156890717,0.920479940680684
255,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,64,Down,0.285550346561526,0.920479940680684
256,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.288256961444743,0.92087234590926
257,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.289935077685123,0.92087234590926
258,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.289977260395637,0.92087234590926
259,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.291016813892835,0.92087234590926
260,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.292795419684676,0.92087234590926
261,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.295897953185959,0.92087234590926
262,WP_NEUROINFLAMMATION,10,Up,0.296220408779793,0.92087234590926
263,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Up,0.296290572329729,0.92087234590926
264,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.296707814669399,0.92087234590926
265,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Down,0.296874904703107,0.92087234590926
266,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Down,0.299544649779684,0.920907386863586
267,WP_GLYOXYLATE_METABOLISM,5,Up,0.300049572747391,0.920907386863586
268,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,12,Up,0.302119479542266,0.920907386863586
269,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,268,Up,0.302359292777692,0.920907386863586
270,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.30269043611014,0.920907386863586
271,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Down,0.304404438974635,0.920907386863586
272,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,12,Down,0.304728478378218,0.920907386863586
273,WP_RANKLRANK_SIGNALING,48,Down,0.310831459103613,0.926004660090666
274,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.31106640010116,0.926004660090666
275,WP_TRYPTOPHAN_METABOLISM,17,Up,0.311752453454937,0.926004660090666
276,WP_RAS_SIGNALING,115,Down,0.313369364566212,0.926004660090666
277,WP_WNT_SIGNALING_WP428,56,Up,0.313578912925936,0.926004660090666
278,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,47,Down,0.313617143523014,0.926004660090666
279,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.315333657383382,0.926004660090666
280,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Down,0.315434294926501,0.926004660090666
281,WP_WNT_SIGNALING_AND_PLURIPOTENCY,58,Up,0.316869501941138,0.926004660090666
282,WP_DRAVET_SYNDROME,12,Up,0.319111110416776,0.926004660090666
283,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.321032142844624,0.926004660090666
284,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.322734424525535,0.926004660090666
285,WP_STEROID_BIOSYNTHESIS,2,Down,0.323440703529627,0.926004660090666
286,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,86,Up,0.324988808645636,0.926004660090666
287,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Up,0.327646750419055,0.926004660090666
288,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.329022827735289,0.926004660090666
289,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.329525133059125,0.926004660090666
290,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.329536949805534,0.926004660090666
291,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,91,Up,0.332057645632709,0.926004660090666
292,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Down,0.332786212998844,0.926004660090666
293,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.333135422274378,0.926004660090666
294,WP_CYTOSINE_METHYLATION,7,Up,0.334961087977369,0.926004660090666
295,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Down,0.335519088170223,0.926004660090666
296,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,56,Up,0.337476810288287,0.926004660090666
297,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,7,Up,0.338473386375844,0.926004660090666
298,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.338476978748503,0.926004660090666
299,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Up,0.339323951992156,0.926004660090666
300,WP_SYNAPTIC_VESICLE_PATHWAY,19,Up,0.341534059460554,0.926004660090666
301,WP_PROSTAGLANDIN_SIGNALING,21,Down,0.341575833731726,0.926004660090666
302,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.342356153270998,0.926004660090666
303,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Down,0.344253744338858,0.926004660090666
304,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,62,Up,0.344457578331143,0.926004660090666
305,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.346880034840008,0.926004660090666
306,WP_NGLYCAN_BIOSYNTHESIS,52,Up,0.346926489434185,0.926004660090666
307,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,46,Up,0.347239712780503,0.926004660090666
308,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,10,Down,0.349512258239521,0.926004660090666
309,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.350252736797912,0.926004660090666
310,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,79,Up,0.351572293466769,0.926004660090666
311,WP_TRANSLATION_FACTORS,49,Down,0.351756357059097,0.926004660090666
312,WP_TAMOXIFEN_METABOLISM,2,Up,0.352890976619441,0.926004660090666
313,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.354395465489917,0.926004660090666
314,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.354574784926636,0.926004660090666
315,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.35646890807958,0.926004660090666
316,WP_TCELL_RECEPTOR_SIGNALING,72,Down,0.356984322567361,0.926004660090666
317,WP_INFLAMMATORY_RESPONSE_PATHWAY,13,Up,0.357599057623892,0.926004660090666
318,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Up,0.359464521401137,0.926004660090666
319,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.360429023133383,0.926004660090666
320,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,62,Up,0.360488432152084,0.926004660090666
321,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.363317899551284,0.927772439472269
322,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,38,Down,0.363433972639988,0.927772439472269
323,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.366336078165356,0.932285623070968
324,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.370079464133194,0.936373208965034
325,WP_MACROPHAGE_MARKERS,8,Down,0.370268363757593,0.936373208965034
326,WP_PPAR_SIGNALING,38,Down,0.372484959102364,0.936373208965034
327,WP_TROP2_REGULATORY_SIGNALING,42,Up,0.373624445940953,0.936373208965034
328,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Up,0.3736379714605,0.936373208965034
329,WP_LUNG_FIBROSIS,29,Down,0.375132070581355,0.937260066923628
330,WP_GASTRIC_CANCER_NETWORK_1,21,Up,0.37705759993695,0.939216203479311
331,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.378432751774514,0.939793721929459
332,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Up,0.38794878956078,0.941593976840239
333,WP_BURN_WOUND_HEALING,59,Down,0.388957415636335,0.941593976840239
334,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Up,0.389227190309505,0.941593976840239
335,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.390744146469983,0.941593976840239
336,WP_PPARALPHA_PATHWAY,15,Down,0.393936613900084,0.941593976840239
337,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,64,Up,0.394664575308528,0.941593976840239
338,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.394803163411718,0.941593976840239
339,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.395415993739172,0.941593976840239
340,WP_NRF2ARE_REGULATION,20,Down,0.396834295345547,0.941593976840239
341,WP_ECTODERM_DIFFERENTIATION,75,Up,0.398773766730211,0.941593976840239
342,WP_IL2_SIGNALING,36,Up,0.400426887748142,0.941593976840239
343,WP_FOXA2_PATHWAY,9,Down,0.400608811858789,0.941593976840239
344,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.403464659384698,0.941593976840239
345,WP_IL6_SIGNALING,39,Up,0.404226078293181,0.941593976840239
346,WP_ZINC_HOMEOSTASIS,23,Up,0.404255867269256,0.941593976840239
347,WP_IL7_SIGNALING,22,Up,0.404692592860838,0.941593976840239
348,WP_IL3_SIGNALING,46,Up,0.405123751741587,0.941593976840239
349,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.406104412126349,0.941593976840239
350,WP_BLOOD_CLOTTING_CASCADE,6,Up,0.406987501331958,0.941593976840239
351,WP_ENDOCHONDRAL_OSSIFICATION,27,Up,0.409705383093367,0.941593976840239
352,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,27,Up,0.409705383093367,0.941593976840239
353,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.411529651174678,0.941593976840239
354,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,21,Down,0.411659646596456,0.941593976840239
355,WP_5Q35_COPY_NUMBER_VARIATION,77,Down,0.412968425746077,0.941593976840239
356,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.414122677300687,0.941593976840239
357,WP_HEME_BIOSYNTHESIS,8,Down,0.414122677300687,0.941593976840239
358,WP_TCA_CYCLE_IN_SENESCENCE,9,Up,0.414381744662131,0.941593976840239
359,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Up,0.416782687903355,0.941593976840239
360,WP_ESTROGEN_SIGNALING,21,Down,0.417070896694502,0.941593976840239
361,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.417222053204699,0.941593976840239
362,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Down,0.417896714073643,0.941593976840239
363,WP_EFFECTS_OF_MFN2_MUTATION,17,Up,0.418332835055738,0.941593976840239
364,WP_CELL_DIFFERENTIATION_INDEX,6,Up,0.420721265697944,0.941593976840239
365,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.42157359409226,0.941593976840239
366,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.422888614570134,0.941593976840239
367,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,15,Down,0.423279414185776,0.941593976840239
368,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.424775965323451,0.941593976840239
369,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.425420043421211,0.941593976840239
370,WP_ENDOMETRIAL_CANCER,49,Up,0.426535562091124,0.941593976840239
371,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,19,Up,0.427323816366945,0.941593976840239
372,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.427582303403404,0.941593976840239
373,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,53,Down,0.427588164668516,0.941593976840239
374,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,13,Up,0.429112941063932,0.941593976840239
375,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,52,Down,0.430409277405647,0.941593976840239
376,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Up,0.431735258567744,0.941593976840239
377,WP_BDNFTRKB_SIGNALING,27,Up,0.432779864183718,0.941593976840239
378,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Down,0.435241517285328,0.941593976840239
379,WP_IL19_SIGNALING,20,Up,0.436558673955951,0.941593976840239
380,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Down,0.437612714391853,0.941593976840239
381,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.440326067096646,0.941593976840239
382,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.440326067096646,0.941593976840239
383,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Down,0.440326800165085,0.941593976840239
384,WP_ONECARBON_METABOLISM,23,Down,0.441537387960964,0.941593976840239
385,WP_REGULATION_OF_ACTIN_CYTOSKELETON,91,Up,0.441792928961518,0.941593976840239
386,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.442159702019869,0.941593976840239
387,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,8,Down,0.443419308122985,0.941836359889132
388,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Up,0.444723922723509,0.941953410512085
389,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Down,0.448608982799992,0.941953410512085
390,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,25,Up,0.448872969080518,0.941953410512085
391,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.448896450713546,0.941953410512085
392,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.450126411287879,0.941953410512085
393,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Up,0.45034998823753,0.941953410512085
394,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.452831409422032,0.942959746306298
395,WP_INTEGRINMEDIATED_CELL_ADHESION,71,Up,0.454571607783135,0.942959746306298
396,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,11,Up,0.455551470734815,0.942959746306298
397,WP_COMPLEMENT_AND_COAGULATION_CASCADES,24,Up,0.457141500892858,0.942959746306298
398,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,24,Up,0.457141500892858,0.942959746306298
399,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.459503533879144,0.942959746306298
400,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.460079292122201,0.942959746306298
401,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.462237536636349,0.942959746306298
402,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,14,Down,0.462437313120562,0.942959746306298
403,WP_KIT_RECEPTOR_SIGNALING,52,Down,0.463594790721559,0.942959746306298
404,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.463961479074604,0.942959746306298
405,WP_LEPTIN_SIGNALING,70,Down,0.464731699003273,0.942959746306298
406,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,45,Up,0.46574410827294,0.942959746306298
407,WP_HEPATITIS_B_INFECTION,116,Up,0.469357921666952,0.946981159810972
408,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,31,Up,0.472187622408198,0.946981159810972
409,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,15,Up,0.472291620408953,0.946981159810972
410,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Up,0.472338534698903,0.946981159810972
411,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.47384236444797,0.94768472889594
412,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Down,0.477333560599155,0.947766950330446
413,WP_FLUOROPYRIMIDINE_ACTIVITY,27,Up,0.478644426595563,0.947766950330446
414,WP_SLEEP_REGULATION,10,Down,0.483112558741998,0.947766950330446
415,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.483418933742996,0.947766950330446
416,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.488229039381213,0.947766950330446
417,WP_ERBB_SIGNALING,68,Down,0.489050101128427,0.947766950330446
418,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,45,Up,0.489837703077857,0.947766950330446
419,WP_TNFALPHA_SIGNALING,83,Up,0.491833942982724,0.947766950330446
420,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.49380143363028,0.947766950330446
421,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.494683423415675,0.947766950330446
422,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Up,0.495923449552292,0.947766950330446
423,WP_ANGIOGENESIS,13,Up,0.498679691242077,0.947766950330446
424,WP_MESODERMAL_COMMITMENT_PATHWAY,75,Down,0.49948075670428,0.947766950330446
425,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,9,Down,0.50024676191009,0.947766950330446
426,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Up,0.500794066222797,0.947766950330446
427,WP_IL11_SIGNALING,41,Up,0.5010866863547,0.947766950330446
428,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.502967813953304,0.947766950330446
429,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Down,0.503424505252261,0.947766950330446
430,WP_GLYCOLYSIS_IN_SENESCENCE,10,Up,0.507718483217551,0.947766950330446
431,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.508404923532402,0.947766950330446
432,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.508670650487753,0.947766950330446
433,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.508693602055482,0.947766950330446
434,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.509235056240084,0.947766950330446
435,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.509381165482062,0.947766950330446
436,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Up,0.512659647509322,0.947766950330446
437,WP_NUCLEOTIDE_GPCRS,5,Up,0.512961734924994,0.947766950330446
438,WP_15Q11Q13_COPY_NUMBER_VARIATION,30,Down,0.513614040731502,0.947766950330446
439,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Down,0.513825569629579,0.947766950330446
440,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,28,Up,0.515146113029986,0.947766950330446
441,WP_AXON_GUIDANCE,36,Up,0.517012033618175,0.947766950330446
442,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.5170460973183,0.947766950330446
443,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.518274546974587,0.947766950330446
444,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Up,0.521477327701666,0.947766950330446
445,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.521643903250126,0.947766950330446
446,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,24,Up,0.521904827734516,0.947766950330446
447,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.523980387281059,0.947766950330446
448,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.524432636852117,0.947766950330446
449,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Up,0.524468133202874,0.947766950330446
450,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.524849835199052,0.947766950330446
451,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,44,Up,0.525951947420103,0.947766950330446
452,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.52651631089437,0.947766950330446
453,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Down,0.526844000308655,0.947766950330446
454,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.52709022923258,0.947766950330446
455,WP_NANOMATERIAL_INDUCED_APOPTOSIS,17,Up,0.527428494908471,0.947766950330446
456,WP_BENZENE_METABOLISM,3,Up,0.52827407959238,0.947766950330446
457,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Down,0.528902446534207,0.947766950330446
458,WP_ALZHEIMERS_DISEASE,184,Up,0.530310431910352,0.947766950330446
459,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Up,0.530310431910352,0.947766950330446
460,WP_MONOAMINE_GPCRS,3,Up,0.530813942626686,0.947766950330446
461,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.532319323936269,0.947766950330446
462,WP_HIPPOYAP_SIGNALING,16,Up,0.532686534127331,0.947766950330446
463,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,12,Up,0.537580090978404,0.952962530099698
464,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Down,0.538106165997043,0.952962530099698
465,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.53908464293961,0.952962530099698
466,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.540772917256953,0.953895575075569
467,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Up,0.543386332959071,0.955531209752268
468,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,48,Down,0.544025068326109,0.955531209752268
469,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.545214724943483,0.955578899581115
470,WP_VITAMIN_D_RECEPTOR_PATHWAY,83,Up,0.546758482182963,0.956245685860416
471,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.553147775390142,0.965366181254134
472,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,34,Up,0.555162477156419,0.96682956826817
473,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.558001924653459,0.96882270537247
474,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.558664187769527,0.96882270537247
475,WP_ENERGY_METABOLISM,40,Down,0.560229544481615,0.969116350282449
476,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.56180128160237,0.969116350282449
477,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,21,Down,0.563494668574303,0.969116350282449
478,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.563549410504879,0.969116350282449
479,WP_IL5_SIGNALING,37,Up,0.56605043842579,0.970457144689484
480,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,75,Up,0.567354268805901,0.970457144689484
481,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Down,0.567890047148844,0.970457144689484
482,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,22,Up,0.569251636504529,0.970457144689484
483,WP_PI3KAKT_SIGNALING,176,Up,0.573039436764213,0.970457144689484
484,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,21,Up,0.57315010810538,0.970457144689484
485,WP_DOPAMINERGIC_NEUROGENESIS,4,Up,0.57483080458711,0.970457144689484
486,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.577576295874204,0.970457144689484
487,WP_HIPPO_SIGNALING_REGULATION,44,Down,0.580006100460777,0.970457144689484
488,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Up,0.581200730075815,0.970457144689484
489,WP_KREBS_CYCLE_DISORDERS,11,Up,0.581571956661471,0.970457144689484
490,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.582118592291574,0.970457144689484
491,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,64,Up,0.582310527526417,0.970457144689484
492,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.582634431911594,0.970457144689484
493,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Up,0.583416159624875,0.970457144689484
494,WP_HEDGEHOG_SIGNALING_WP4249,25,Down,0.584467271190134,0.970457144689484
495,WP_NAD_METABOLISM,11,Up,0.585668220713617,0.970457144689484
496,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Down,0.586399293774111,0.970457144689484
497,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,40,Down,0.586760585049481,0.970457144689484
498,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,119,Up,0.588285978867706,0.97102625427561
499,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,53,Up,0.593087484113294,0.973423409032926
500,WP_DNA_REPLICATION,41,Up,0.59695137696292,0.973423409032926
501,WP_GPR40_PATHWAY,10,Down,0.597260859645976,0.973423409032926
502,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,67,Down,0.598896059293754,0.973423409032926
503,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Down,0.598928905171458,0.973423409032926
504,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.599491311703764,0.973423409032926
505,WP_FATTY_ACID_BETAOXIDATION,28,Up,0.599688081617597,0.973423409032926
506,WP_B_CELL_RECEPTOR_SIGNALING,86,Down,0.600422582000233,0.973423409032926
507,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,75,Down,0.601443445268815,0.973423409032926
508,WP_FERROPTOSIS,50,Up,0.602246903448681,0.973423409032926
509,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.602764617028904,0.973423409032926
510,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.607863436580676,0.97363438895964
511,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.609296262519277,0.97363438895964
512,WP_TP53_NETWORK,16,Down,0.60982720709258,0.97363438895964
513,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.610865659624063,0.97363438895964
514,WP_MELANOMA,56,Up,0.611491148161218,0.97363438895964
515,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Down,0.611817478157008,0.97363438895964
516,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Up,0.61320819316522,0.97363438895964
517,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.616066632896739,0.97363438895964
518,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Up,0.616186602605907,0.97363438895964
519,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,48,Down,0.616620082406285,0.97363438895964
520,WP_OSTEOPONTIN_SIGNALING,11,Down,0.620456000106701,0.97363438895964
521,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.621566823836363,0.97363438895964
522,WP_GASTRIN_SIGNALING,92,Up,0.626584884814392,0.97363438895964
523,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.62985290594467,0.97363438895964
524,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.63057365126913,0.97363438895964
525,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.634251363691404,0.97363438895964
526,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.63556505955593,0.97363438895964
527,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.635784669332578,0.97363438895964
528,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Up,0.636694803678416,0.97363438895964
529,WP_OVARIAN_INFERTILITY,23,Up,0.639008986333311,0.97363438895964
530,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.639235472965509,0.97363438895964
531,WP_VITAMIN_D_METABOLISM,6,Up,0.641429036611524,0.97363438895964
532,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,11,Down,0.642882700773997,0.97363438895964
533,WP_NEURAL_CREST_DIFFERENTIATION,38,Up,0.645138262860243,0.97363438895964
534,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,23,Up,0.645750393692888,0.97363438895964
535,WP_NRXN1_DELETION_SYNDROME,2,Down,0.647053993192498,0.97363438895964
536,WP_HOMOLOGOUS_RECOMBINATION,13,Up,0.647962481365986,0.97363438895964
537,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,40,Up,0.648612553054903,0.97363438895964
538,WP_CORI_CYCLE,11,Down,0.649415377431874,0.97363438895964
539,WP_INSULIN_SIGNALING,130,Down,0.650209566976824,0.97363438895964
540,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,20,Up,0.650944384987837,0.97363438895964
541,WP_PROLACTIN_SIGNALING,69,Up,0.653950964836984,0.97363438895964
542,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.655794175469574,0.97363438895964
543,WP_ETHER_LIPID_BIOSYNTHESIS,15,Down,0.6558951482126,0.97363438895964
544,WP_CIRCADIAN_RHYTHM_GENES,118,Down,0.656535149987279,0.97363438895964
545,WP_SPINAL_CORD_INJURY,64,Up,0.658348395332031,0.97363438895964
546,WP_OPIOID_RECEPTOR_PATHWAYS,25,Down,0.658577463663238,0.97363438895964
547,WP_DNA_MISMATCH_REPAIR,23,Down,0.658761769366067,0.97363438895964
548,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.660534000228331,0.97363438895964
549,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.662864686588501,0.97363438895964
550,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.662864686588501,0.97363438895964
551,WP_PROTEASOME_DEGRADATION,57,Down,0.662966202845281,0.97363438895964
552,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,24,Down,0.663436210248172,0.97363438895964
553,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Down,0.666939153561052,0.97363438895964
554,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.672964083632277,0.97363438895964
555,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,11,Down,0.673303059687363,0.97363438895964
556,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,8,Down,0.673428239907561,0.97363438895964
557,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,8,Down,0.673428239907561,0.97363438895964
558,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.674533826553945,0.97363438895964
559,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Up,0.675449466602358,0.97363438895964
560,WP_ACE_INHIBITOR_PATHWAY,4,Up,0.679409434947554,0.97363438895964
561,WP_TRANSSULFURATION_PATHWAY,8,Down,0.680575025054298,0.97363438895964
562,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,12,Up,0.682516290391545,0.97363438895964
563,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,43,Down,0.682847076972437,0.97363438895964
564,WP_CELLULAR_PROTEOSTASIS,6,Down,0.683156431585142,0.97363438895964
565,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.68333171866197,0.97363438895964
566,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,53,Down,0.683749150220726,0.97363438895964
567,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Down,0.684590630321034,0.97363438895964
568,WP_IL17_SIGNALING,25,Down,0.686125149372378,0.97363438895964
569,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.686754597953647,0.97363438895964
570,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.688169980816492,0.97363438895964
571,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.68985964619396,0.97363438895964
572,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.691847244404614,0.97363438895964
573,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.691881381125063,0.97363438895964
574,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,35,Up,0.695907988211328,0.97363438895964
575,WP_MATRIX_METALLOPROTEINASES,8,Up,0.696198913050337,0.97363438895964
576,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Up,0.697163590117109,0.97363438895964
577,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.697845629701578,0.97363438895964
578,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Down,0.698615737939094,0.97363438895964
579,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.700453390936051,0.97363438895964
580,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,63,Up,0.700612019811266,0.97363438895964
581,WP_TYPE_II_DIABETES_MELLITUS,13,Down,0.7014120211317,0.97363438895964
582,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.704559529061086,0.97363438895964
583,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.707075617568673,0.97363438895964
584,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,72,Down,0.70840280421695,0.97363438895964
585,WP_BLADDER_CANCER,29,Down,0.708524434574892,0.97363438895964
586,WP_ALPHA_6_BETA_4_SIGNALING,25,Up,0.709976021426931,0.97363438895964
587,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Down,0.71040088884794,0.97363438895964
588,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.715559493909591,0.97363438895964
589,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,84,Up,0.716301582565022,0.97363438895964
590,WP_SMALL_CELL_LUNG_CANCER,70,Down,0.717328547178398,0.97363438895964
591,WP_MITOCHONDRIAL_GENE_EXPRESSION,17,Down,0.717450908828165,0.97363438895964
592,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.721235804320342,0.97363438895964
593,WP_TGFBETA_RECEPTOR_SIGNALING,35,Down,0.721512889634109,0.97363438895964
594,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.722566420925837,0.97363438895964
595,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Up,0.723259070464637,0.97363438895964
596,WP_APOPTOSIS,71,Up,0.72344922889711,0.97363438895964
597,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.72372099255998,0.97363438895964
598,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,17,Up,0.724513403952792,0.97363438895964
599,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.724628833530273,0.97363438895964
600,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,9,Up,0.724953275657386,0.97363438895964
601,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,81,Up,0.724953761469905,0.97363438895964
602,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,6,Down,0.72634251676275,0.97363438895964
603,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.729426386605553,0.97363438895964
604,WP_NEOVASCULARIZATION_PROCESSES,22,Up,0.731694054554715,0.97363438895964
605,WP_NETRINUNC5B_SIGNALING,35,Up,0.732176104375438,0.97363438895964
606,WP_PHOSPHOINOSITIDES_METABOLISM,39,Down,0.732391586703521,0.97363438895964
607,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,44,Up,0.733155714282045,0.97363438895964
608,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Down,0.733263349702142,0.97363438895964
609,WP_GENES_CONTROLLING_NEPHROGENESIS,12,Down,0.733621842782476,0.97363438895964
610,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,52,Up,0.734545461013762,0.97363438895964
611,WP_MIRNA_BIOGENESIS,6,Down,0.73468714721328,0.97363438895964
612,WP_IL9_SIGNALING,14,Up,0.735226383431594,0.97363438895964
613,WP_METHYLATION_PATHWAYS,5,Up,0.735307312372234,0.97363438895964
614,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,29,Down,0.737720860687062,0.97363438895964
615,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,25,Down,0.739109629181849,0.97363438895964
616,WP_DOPAMINE_METABOLISM,7,Down,0.7418185078018,0.97363438895964
617,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.744371976029976,0.97363438895964
618,WP_METASTATIC_BRAIN_TUMOR,6,Up,0.746605006130697,0.97363438895964
619,WP_VITAMIN_B12_DISORDERS,9,Up,0.747525887388792,0.97363438895964
620,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.748234006801241,0.97363438895964
621,WP_OSTEOBLAST_SIGNALING,2,Down,0.748944934902952,0.97363438895964
622,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.751470040831875,0.97363438895964
623,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.751632536005504,0.97363438895964
624,WP_PYRIMIDINE_METABOLISM,74,Down,0.752122029818278,0.97363438895964
625,WP_EBOLA_VIRUS_INFECTION_IN_HOST,108,Up,0.75280298467114,0.97363438895964
626,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,66,Up,0.754264560658445,0.97363438895964
627,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Down,0.755335395422099,0.97363438895964
628,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Up,0.755531417014739,0.97363438895964
629,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Up,0.757966210960577,0.97363438895964
630,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.75950043187645,0.97363438895964
631,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,39,Up,0.760168958087285,0.97363438895964
632,WP_PURINE_METABOLISM,10,Down,0.760559008116493,0.97363438895964
633,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Down,0.76101203768197,0.97363438895964
634,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Down,0.763056653380147,0.97363438895964
635,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,61,Down,0.763985188151986,0.97363438895964
636,WP_VEGFAVEGFR2_SIGNALING,342,Up,0.765475576631356,0.97363438895964
637,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,60,Up,0.766059576647338,0.97363438895964
638,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.767563307805087,0.97363438895964
639,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,164,Up,0.767626300466532,0.97363438895964
640,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Down,0.769305374562174,0.97363438895964
641,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.770779144442199,0.97363438895964
642,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.770785660261176,0.97363438895964
643,WP_IL1_SIGNALING,53,Down,0.771246321879548,0.97363438895964
644,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.774114083911111,0.97363438895964
645,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,10,Up,0.776859707282815,0.97363438895964
646,WP_13Q1212_COPY_NUMBER_VARIATION,19,Up,0.779017636730624,0.97363438895964
647,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,30,Up,0.77997120612845,0.97363438895964
648,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.780902393530807,0.97363438895964
649,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Down,0.781819339145861,0.97363438895964
650,WP_TAR_SYNDROME,44,Down,0.7820064097219,0.97363438895964
651,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,16,Up,0.782606455282539,0.97363438895964
652,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Up,0.78326620593682,0.97363438895964
653,WP_SPHINGOLIPID_PATHWAY,21,Down,0.783942780783601,0.97363438895964
654,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.785142066595552,0.97363438895964
655,WP_WNT_SIGNALING_WP363,37,Down,0.787059866715503,0.97363438895964
656,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,135,Down,0.789071744699401,0.97363438895964
657,WP_HISTONE_MODIFICATIONS,37,Down,0.790944535143421,0.97363438895964
658,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.791235105996253,0.97363438895964
659,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Up,0.792632937713688,0.97363438895964
660,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.793167377182652,0.97363438895964
661,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.794176760507818,0.97363438895964
662,WP_ALLOGRAFT_REJECTION,50,Down,0.794807112920628,0.97363438895964
663,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Down,0.795037027497013,0.97363438895964
664,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.795198999431641,0.97363438895964
665,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Up,0.796001604500022,0.97363438895964
666,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,49,Up,0.796326378418416,0.97363438895964
667,WP_GALANIN_RECEPTOR_PATHWAY,10,Down,0.797644480884354,0.97363438895964
668,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,49,Up,0.798035516490126,0.97363438895964
669,WP_CANCER_PATHWAYS,304,Up,0.798222753584214,0.97363438895964
670,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.799403741913934,0.97363438895964
671,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.800969377352113,0.97363438895964
672,WP_AEROBIC_GLYCOLYSIS,10,Up,0.802312668458923,0.97363438895964
673,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.802312668458923,0.97363438895964
674,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Down,0.803048077765182,0.97363438895964
675,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.803106832963836,0.97363438895964
676,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,21,Up,0.803641047197549,0.97363438895964
677,WP_4P163_COPY_NUMBER_VARIATION,22,Up,0.80458969277759,0.97363438895964
678,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Up,0.805185968329929,0.97363438895964
679,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.805436748324741,0.97363438895964
680,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.805439640501892,0.97363438895964
681,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Up,0.80730049929471,0.974450822937227
682,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.810480735325846,0.976855079820888
683,WP_AUTOPHAGY,27,Up,0.81276729814449,0.977098499467018
684,WP_MONOAMINE_TRANSPORT,12,Up,0.813060065249927,0.977098499467018
685,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.81481055223543,0.977261226077251
686,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Up,0.815573237334542,0.977261226077251
687,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,16,Up,0.819815599902384,0.978344578171566
688,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Up,0.82002949452504,0.978344578171566
689,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,5,Down,0.826621140998466,0.978344578171566
690,WP_KININKALLIKREIN_PATHWAY,2,Up,0.828080092544626,0.978344578171566
691,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,31,Up,0.831230198024808,0.978344578171566
692,WP_NOTCH_SIGNALING_WP268,35,Up,0.832968299846853,0.978344578171566
693,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,8,Down,0.833013547213798,0.978344578171566
694,WP_MEASLES_VIRUS_INFECTION,101,Down,0.834214070344836,0.978344578171566
695,WP_NUCLEAR_RECEPTORS_METAPATHWAY,171,Down,0.834488854532256,0.978344578171566
696,WP_LUNG_PATHOLOGY_OF_COVID19,14,Down,0.834591082040911,0.978344578171566
697,WP_G_PROTEIN_SIGNALING,63,Up,0.838221947308932,0.978344578171566
698,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Up,0.838686021940371,0.978344578171566
699,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,2,Up,0.838881538818353,0.978344578171566
700,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.839259612875178,0.978344578171566
701,WP_ESTROGEN_METABOLISM_WP697,5,Down,0.839930365826768,0.978344578171566
702,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Up,0.840056451461493,0.978344578171566
703,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.84007628463372,0.978344578171566
704,WP_ATM_SIGNALING,37,Up,0.842157504673172,0.978344578171566
705,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.842553305590128,0.978344578171566
706,WP_TGFB_SMAD_SIGNALING,7,Down,0.842892942522854,0.978344578171566
707,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.843653557358137,0.978344578171566
708,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,9,Down,0.845145411266509,0.978344578171566
709,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,34,Up,0.847409776239708,0.978344578171566
710,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Down,0.848805723262441,0.978344578171566
711,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Down,0.849076964017389,0.978344578171566
712,WP_TYPE_II_INTERFERON_SIGNALING,30,Up,0.851640299027371,0.978344578171566
713,WP_UROTENSINIIMEDIATED_SIGNALING,50,Down,0.853394354514958,0.978344578171566
714,WP_MAPK_CASCADE,30,Up,0.856362619115989,0.978344578171566
715,WP_16P112_PROXIMAL_DELETION_SYNDROME,60,Up,0.857039818363729,0.978344578171566
716,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.857481007180081,0.978344578171566
717,WP_TCELL_ACTIVATION_SARSCOV2,62,Up,0.857774154777111,0.978344578171566
718,WP_GASTRIC_CANCER_NETWORK_2,27,Down,0.858347143664662,0.978344578171566
719,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,19,Up,0.859706089619204,0.978344578171566
720,WP_HUNGER_AND_SATIETY,2,Up,0.859714254975275,0.978344578171566
721,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.860469428982344,0.978344578171566
722,WP_COMPLEMENT_SYSTEM,50,Down,0.860639997912749,0.978344578171566
723,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.861183179043445,0.978344578171566
724,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.866098845410639,0.978344578171566
725,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,85,Down,0.866284144789693,0.978344578171566
726,WP_METABOLIC_EPILEPTIC_DISORDERS,58,Up,0.866488234997465,0.978344578171566
727,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.866743897091948,0.978344578171566
728,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,4,Down,0.86716788922425,0.978344578171566
729,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Up,0.867655958013469,0.978344578171566
730,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,15,Down,0.870459925819856,0.979817723503805
731,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Up,0.872898510485266,0.979817723503805
732,WP_NUCLEOTIDE_EXCISION_REPAIR,44,Down,0.872972006392271,0.979817723503805
733,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,172,Down,0.873730403075777,0.979817723503805
734,WP_EGFEGFR_SIGNALING,139,Up,0.882605906874662,0.981467638114207
735,WP_NONSMALL_CELL_LUNG_CANCER,60,Up,0.883134455880261,0.981467638114207
736,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.883322306211193,0.981467638114207
737,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.883961071645287,0.981467638114207
738,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.886883408107044,0.981467638114207
739,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,77,Down,0.887203568723511,0.981467638114207
740,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,28,Up,0.888946265712619,0.981467638114207
741,WP_PDGFRBETA_PATHWAY,28,Down,0.890713785692801,0.981467638114207
742,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.892892389912535,0.981467638114207
743,WP_IL4_SIGNALING,50,Up,0.893336966033021,0.981467638114207
744,WP_MALE_INFERTILITY,70,Down,0.894136496502091,0.981467638114207
745,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,34,Up,0.897400279062434,0.981467638114207
746,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Up,0.903486740426402,0.981467638114207
747,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.903666798476384,0.981467638114207
748,WP_MAPK_SIGNALING,159,Down,0.904091058759526,0.981467638114207
749,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.904552147938799,0.981467638114207
750,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.906489030529773,0.981467638114207
751,WP_PRIMARY_OVARIAN_INSUFFICIENCY,96,Up,0.908790661757058,0.981467638114207
752,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.908816792518282,0.981467638114207
753,WP_IRINOTECAN_PATHWAY,5,Down,0.910209972662072,0.981467638114207
754,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Down,0.910626540327299,0.981467638114207
755,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Up,0.911252065989671,0.981467638114207
756,WP_ATR_SIGNALING,10,Up,0.912623424161752,0.981467638114207
757,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,42,Down,0.913412374545895,0.981467638114207
758,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.913897040186202,0.981467638114207
759,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Up,0.914111966809958,0.981467638114207
760,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.915095657464099,0.981467638114207
761,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.915465282272843,0.981467638114207
762,WP_CAMKK2_PATHWAY,29,Down,0.915830098679162,0.981467638114207
763,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.916304142849714,0.981467638114207
764,WP_SEROTONIN_AND_ANXIETY,6,Up,0.91708101518753,0.981467638114207
765,WP_KLEEFSTRA_SYNDROME,24,Up,0.917825138851278,0.981467638114207
766,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Down,0.918844863555027,0.981467638114207
767,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Down,0.919643568843982,0.981467638114207
768,WP_CHEMOKINE_SIGNALING,108,Up,0.919797095190971,0.981467638114207
769,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Up,0.920568248964056,0.981467638114207
770,WP_P38_MAPK_SIGNALING,31,Down,0.920783094349202,0.981467638114207
771,WP_KETOGENESIS_AND_KETOLYSIS,7,Down,0.922655582611526,0.981467638114207
772,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Down,0.925676138206323,0.981467638114207
773,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,69,Down,0.927473239800506,0.981467638114207
774,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,29,Down,0.930300629842264,0.981467638114207
775,WP_AGERAGE_PATHWAY,54,Up,0.930670699826156,0.981467638114207
776,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,88,Down,0.9312843094659,0.981467638114207
777,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Up,0.931878183553225,0.981467638114207
778,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,75,Down,0.931959961414877,0.981467638114207
779,WP_MTHFR_DEFICIENCY,18,Down,0.932142945995258,0.981467638114207
780,WP_NRF2_PATHWAY,66,Down,0.932325114662678,0.981467638114207
781,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Up,0.936455385477436,0.981467638114207
782,WP_ID_SIGNALING,12,Down,0.937744185111357,0.981467638114207
783,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.937948041800536,0.981467638114207
784,WP_RETINOL_METABOLISM,6,Up,0.938002777560719,0.981467638114207
785,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Up,0.938549321601322,0.981467638114207
786,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.939168353032516,0.981467638114207
787,WP_PDGF_PATHWAY,36,Up,0.93967765352297,0.981467638114207
788,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.942321206977341,0.982979736212404
789,WP_ONCOSTATIN_M_SIGNALING,54,Down,0.946148756525017,0.985368414073637
790,WP_BASE_EXCISION_REPAIR,31,Down,0.947008573136464,0.985368414073637
791,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.950423236579974,0.987671176319518
792,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.955921386881916,0.988158971844718
793,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.956522743429144,0.988158971844718
794,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,42,Down,0.957920253111957,0.988158971844718
795,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,58,Down,0.960410750696582,0.988158971844718
796,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.960503048626773,0.988158971844718
797,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Down,0.961852125950341,0.988158971844718
798,WP_GPCRS_OTHER,11,Up,0.962082535115228,0.988158971844718
799,WP_15Q25_COPY_NUMBER_VARIATION,27,Up,0.962307973458246,0.988158971844718
800,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.962822065652976,0.988158971844718
801,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.96291403460781,0.988158971844718
802,WP_GLIOBLASTOMA_SIGNALING,69,Up,0.964454307059384,0.988505536661862
803,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.969394144676948,0.992331241499939
804,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,8,Down,0.975275352033758,0.996163177288178
805,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.975840080495571,0.996163177288178
806,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.976917541888749,0.996163177288178
807,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.977985017118686,0.996163177288178
808,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,22,Down,0.981335146405816,0.996689525052583
809,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.981692792465125,0.996689525052583
810,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,57,Up,0.983767146419306,0.996689525052583
811,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.984411785033918,0.996689525052583
812,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Down,0.98456434834878,0.996689525052583
813,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,19,Up,0.989611681297985,0.999691359852824
814,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.990219574898023,0.999691359852824
815,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Down,0.992805845517858,0.999691359852824
816,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.995060799182764,0.999691359852824
817,WP_ACUTE_VIRAL_MYOCARDITIS,63,Up,0.995587086916608,0.999691359852824
818,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Down,0.9962002936126,0.999691359852824
819,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Down,0.996276122679291,0.999691359852824
820,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Up,0.997726473859455,0.999691359852824
821,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.998787061633181,0.999691359852824
822,WP_PLEURAL_MESOTHELIOMA,251,Down,0.999691359852824,0.999691359852824
